2seventy bio Q2 EPS $(0.83) Up From $(2.02) YoY, Sales $36.05M Up From $13.48M YoY
Portfolio Pulse from Benzinga Newsdesk
2seventy bio reported Q2 losses of $(0.83) per share, a 58.91% increase YoY. The company also reported $36.05M in sales, a 167.38% increase YoY.
August 14, 2023 | 11:06 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
2seventy bio reported a YoY increase in losses but also a significant increase in sales.
While the company reported an increase in losses, the significant increase in sales could offset this in the eyes of investors. The impact on the stock price could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100